Media

PSMA PET CT, A Mixed Blessing - Interview with Ian Davis

Details
Professor Ian Davis joins Carmel Pezaro to discuss the pitfalls of PSMA PET CT scans at the Advanced Prostate Cancer Consensus Conference (APCCC 2019). Starting the discussion on the disadvantages of PSMA PET, Professor Davis refers to PSMA PET as a bit of a mixed blessing and the challenge being the amount of enthusiasm for it and trying to bring it into clinical practice in a meaningful way. Wit...

Innovate to Elevate the Practice of Urology - Arie Belldegrun

Details
Arie Belldegrun discusses innovation as a critical element in elevating the practice of urology. He emphasizes that all urologists hold the potential for driving innovation in urology. Biographies: Arie Belldegrun, MD, FACS, Arie S. Belldegrun MD. FACS, is an Israeli-born American urologic oncologist, businessman, and investor. Related Content: Growth in Urology Through Innovation - Abel Ang Read...

Surgical Breakthroughs in the Management of Obstructive Bladder Disease - Joshua Mauney

Details
Joshua Mauney speaks about surgical breakthroughs in the management of obstructive bladder disease which includes a rat model of neurogenic bladder, fetal ovine exstrophy, as well as a model created in our laboratory for partial bladder outlet obstruction in swine. Biographies: Joshua Mauney, Ph.D., Department of Urology, Boston Children's Hospital, Assistant Professor of Surgery, Harvard Medical...

Overcoming the Limitations of Laparoscopy - Kurt Azarbarzin

Details
Kurt Azarbarzin speaks on the limitations associated with laparoscopy, and how ConMed's AirSeal System aims to overcome these limitations. Biography Kurt Azarbarzin, President & CEO Verb Surgical, and a member of the board of directors. He brings over 30 years of medical device industry and surgery market experience to the company. In his most recent role, he was Chief Technology Officer at ConMed...

Advice for the Application Process, Urology Residency - Gordon Brown

Details
Four Rising Chief Residents join Gordon Brown at the 2019 Rising Chief Resident Summit in a discussion offering invaluable advice for the application process and steps you can take to position yourself above the rest when applying for a residency. The Rising Chief Residents Summit is put together by the Large Urology Group Practice Association. This summit aims to support post-graduate year 4 and...

Overcoming Hurdles for Soon-To-Be Practitioners, The Rising Chief Resident Summit - Tom Stringer

Details
Tom Stringer joins Neal Shore to share highlights of his presentation at the first Rising Chief Residents Summit put together by the Large Urology Group Practice Association. This summit aims to support post-graduate year 4 and 5 residents during their transition to full-time practice. Dr. Stringer presented on crucial topics including vetting employment contracts, pursuing a career in academia, h...

Radiation Therapy Options for Men with Clinically Node-Positive Prostate Cancer - Mack Roach

Details
In this conversation with Charles Ryan, MD, Mack Roach III, MD discusses radiotherapy options for patients with clinically node-positive prostate cancer. In particularly with oligometastatic disease we are seeing long-term follow-up from a number of trials and have begun integrating data from these trials into clinical practice. Biographies: Mack Roach III, MD, Professor of Radiation Oncology and...

The Future of Biomarkers in Advanced Prostate Cancer - Mark Rubin

Details
In this conversation with Charles Ryan, Mark Rubin highlights the key points he addresses in his 2019 Advanced Prostate Cancer Consensus Conference presentation where he speaks about the future of biomarkers in advanced prostate cancer. Biographies: Mark A. Rubin, MD, Professor, Principal Investigator, and Director Department for BioMedical Research (DBMR), University of Bern, Switzerland. Dr. Rub...

Management of Castration-Resistant Prostate Cancer - Cora Sternberg

Details
Cora Sternberg joins Alicia Morgans and shares highlights from the Management of castration-resistant prostate cancer session at the 2019 Advanced Prostate Cancer Consensus Conference (APCCC) and key takeaways from the session when thinking about managing these patients with this disease. She highlights Professor Michael Hofman's presentation on PSMA Targeted Therapies focusing on Lutetium PSMA sc...

Guiding First Line Treatment Decisions for mCRPC After ADT + Docetaxel or AR Pathway Inhibitor - Mary-Ellen Taplin

Details
Mary-Ellen Taplin joins Alicia Morgans to share highlights from her 2019 Advanced Prostate Cancer Consensus Conference (APCCC) presentation on first line treatment of metastatic castration-resistant prostate cancer (mCRPC) after patients have received either docetaxel or abiraterone, enzalutamide, or apalutamide and the lack of data to guide treating physicians in this treatment setting. She highl...